Phase III quality-of-life study results: impact on patients’ quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer—RTOG 97-09

To determine whether prevention of hyposalivation after curative radiotherapy (RT) to the head and neck improves patients’ quality of life (QOL). Patients were to receive at least 50 Gy to 50% of the volume of the major salivary glands, provide unstimulated and stimulated saliva samples, and complet...

Ausführliche Beschreibung